Publications by authors named "Sandeep K Jain"

Introduction: Real-world studies comparing safety and efficacy of combined percutaneous left atrial appendage occlusion (LAAO) and catheter ablation (CA) to LAAO alone are limited.

Methods: Patients from a large US hospital system undergoing combined LAAO and left-atrial CA from 8/2020 to 2/2024 were retrospectively analyzed and compared to a control group undergoing LAAO alone. Controls were identified using a 1:2 propensity score match based on LAAO device type (Watchman FLX vs.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on predicting major bleeding events in patients with non-valvular atrial fibrillation who are taking direct oral anticoagulants (DOACs), emphasizing the importance of these predictions for personalized treatment and overall patient care improvements.
  • The objective is to compare the effectiveness of machine learning models against traditional bleeding risk scores (like HAS-BLED and ORBIT) in forecasting serious bleeding incidents that require hospitalization.
  • Conducted at the University of Pittsburgh Medical Center with a cohort of 24,468 patients, the findings revealed that 2.3% experienced bleeding within one year, and the study explored various machine learning models to predict these events, showing only modest improvements over standard methods.
View Article and Find Full Text PDF
Article Synopsis
  • In patients with atherosclerotic cardiovascular disease, increased age is linked to higher risks of both ischemic and bleeding events, prompting a study on the effect of aspirin dosage based on age.
  • The ADAPTABLE trial involved nearly 15,100 participants who were randomly assigned to take either 81 mg or 325 mg of aspirin daily, with outcomes measured over an average follow-up of 26.2 months.
  • Results indicated that age did not significantly affect how aspirin dosage influenced clinical outcomes, suggesting that both doses are similarly effective for elderly and younger patients in preventing cardiovascular events.
View Article and Find Full Text PDF

Background: Implantable cardioverter-defibrillation (ICD) shocks after left ventricular assist device therapy (LVAD) are associated with adverse clinical outcomes. Little is known about the association of pre-LVAD ICD shocks on post-LVAD clinical outcomes and whether LVAD therapy affects the prevalence of ICD shocks.

Objectives: The purpose of this study was to determine whether pre-LVAD ICD shocks are associated with adverse clinical outcomes post-LVAD and to compare the prevalence of ICD shocks before and after LVAD therapy.

View Article and Find Full Text PDF
Article Synopsis
  • The ADAPTABLE trial, a large study on aspirin dosing for preventing heart issues, showed no significant difference in efficacy between high- and low-dose aspirin in patients with cardiovascular disease.
  • It explored whether using P2Y12 inhibitors like clopidogrel or prasugrel impacted aspirin's effectiveness or safety; however, results indicated no interaction between aspirin dose and P2Y12 inhibitor use.
  • Participants taking P2Y12 inhibitors had a higher risk of major cardiovascular events but not an increased risk of bleeding, and switching doses was more common in the high-dose group without being influenced by P2Y12 inhibitor status.
View Article and Find Full Text PDF
Article Synopsis
  • Clinicians recommend enteric-coated aspirin to reduce gastrointestinal bleeding for patients with coronary artery disease, despite evidence suggesting it may be less effective at inhibiting platelets than uncoated aspirin.
  • This study analyzed data from the ADAPTABLE trial, which involved over 15,000 patients with atherosclerotic cardiovascular disease, to compare the effectiveness and safety of enteric-coated versus uncoated aspirin.
  • The primary outcomes measured were the occurrence of major cardiovascular events and major bleeding incidents, with findings indicating the differences in these outcomes between the two aspirin formulations over approximately 26 months of follow-up.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD) were studied to determine the impact of different aspirin doses on cardiovascular risks and bleeding events.* -
  • The research involved 15,076 patients, revealing that those with DM had higher rates of cardiovascular issues and bleeding compared to those without DM, regardless of whether they took 81 mg or 325 mg of aspirin.* -
  • The results indicate that increasing the dose of aspirin does not provide additional benefits for patients with DM, highlighting their increased risk in general rather than a response to medication.*
View Article and Find Full Text PDF

Background Over the next few years, atrial fibrillation (AF)-related morbidity and costs will increase significantly. Thus, it is prudent to examine the impact of AF treatment on health care resource use. This study examined the impact of AF ablation on hospitalization, length of stay, and resource use for patients undergoing AF ablation in a multihospital system.

View Article and Find Full Text PDF
Article Synopsis
  • - The ADAPTABLE trial examined the effects of different doses of aspirin (81 mg vs 325 mg daily) on cardiovascular events and bleeding rates in patients with existing cardiovascular disease, finding no significant differences between the two doses.
  • - In a secondary analysis focusing on patients with chronic kidney disease (CKD), results showed that CKD patients had a higher risk of adverse cardiovascular outcomes and major bleeding, regardless of the aspirin dose they were taking.
  • - The study concluded that while CKD increased the risk for complications, the dosing of aspirin did not affect the risk of adverse events or bleeding in these patients.
View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is a prevalent arrhythmia, that causes thrombus formation, ordinarily in the left atrial appendage (LAA). The conventional metric of stroke risk stratification, CHADS-VASc score, does not account for LAA morphology or hemodynamics. We showed in our previous study that residence time distribution (RTD) of blood-borne particles in the LAA and its associated calculated variables (i.

View Article and Find Full Text PDF

Background: In mild-to-moderate cardiomyopathy, cardiac resynchronization therapy (CRT) is indicated in patients with high burden of right ventricular pacing but not in those with intrinsic ventricular conduction abnormalities.

Hypothesis: We hypothesized that CRT positively impacts outcomes of patients with intrinsic ventricular conduction delay and left ventricular ejection fraction (LVEF) of 36%-50%.

Methods: Of 18 003 patients with LVEF ≤ 50%, 5966 (33%) patients had mild-to-moderate cardiomyopathy, of whom 1741 (29%) have a QRS duration ≥120 ms.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) affects millions of Americans each year and can lead to high levels of resource utilization through emergency department (ED) visits and inpatient stays.

Hypothesis: We hypothesized that referral of patients to a dedicated Center for AF from the ED would reduce costs of care.

Methods: The University of Pittsburgh Center for AF serves as a rapid referral center for patients with AF to avoid unnecessary inpatient admissions and provide specialized care.

View Article and Find Full Text PDF

Background: Left ventricular hypertrophy (LVH) is common in patients with atrial fibrillation (AF), however, many antiarrhythmic drugs (AADs) are contraindicated. US guidelines recommend avoiding pure class III antiarrhythmics such as dofetilide in patients with significant LVH due to concern for an increased risk of death, however, clinical data is lacking. We sought to determine if dofetilide use was associated with increased mortality in patients with LVH.

View Article and Find Full Text PDF

This is the first report describing atrioventricular junction ablation during sinus rhythm in a patient with persistent left superior vena cava. Electroanatomic mapping systems and awareness of anatomic and electrogram variations may decrease procedure time, decrease fluoroscopy time, and minimize delivery of ineffective ablation lesions.

View Article and Find Full Text PDF
Article Synopsis
  • Modern guideline-directed medical therapy (GDMT) significantly improves survival rates for patients with heart failure with reduced ejection fraction (HFrEF) compared to older treatments used in past research.
  • The study analyzed data from nearly 5,000 patients with primary prevention implantable cardioverter-defibrillators (ICDs) and examined how the number of GDMT medications influenced mortality rates over two years.
  • Results showed that each additional GDMT medication lowered the risk of death by 36% for ICD recipients and 30% for CRT-D recipients, suggesting that maximizing GDMT use should be prioritized for improving patient survival.
View Article and Find Full Text PDF

Cardiac resynchronization therapy (CRT) is an established treatment of patients with heart failure with reduced ejection fraction and prolonged ventricular depolarization on surface electrocardiogram. Although patients' characteristics, such as their type of cardiomyopathy and the morphology and width of their baseline QRS complex, have been associated with CRT response, these features are not modifiable. Left ventricular multisite pacing has been proposed and tested as a tool to improve response to CRT and positively impact patient outcomes.

View Article and Find Full Text PDF

Although ventricular dysfunction is associated with the occurrence of ventricular arrhythmia (VA), most patients with cardiomyopathy do not experience VA. We therefore investigated other predictors of VA in a large contemporary cohort of patients with cardiomyopathy. All patients at a large academic medical system with left ventricular ejection fraction (LVEF) ≤50% were enrolled at the time of first documented low LVEF.

View Article and Find Full Text PDF
Article Synopsis
  • Cardiac resynchronization therapy (CRT) shows potential benefits in patients with permanent atrial fibrillation (AF) but limited data exists on its effectiveness, leading to the investigation of atrio-ventricular junctional ablation (AVJA).
  • A study involving 26 patients randomized to receive CRT-D with or without AVJA found no significant difference in left ventricular end-systolic volume (LVESV) improvement between the two groups at 6 months.
  • Although AVJA didn't appear to enhance outcomes, CRT demonstrated effectiveness overall in improving left ventricular ejection fraction (LVEF) and functional class among patients with AF.
View Article and Find Full Text PDF

Several studies have reported circadian periodicity of sudden cardiac arrest (SCA). It remains unclear to what extent this circadian rhythm is influenced by variation in patients' activities. One way to elucidate this is to compare patients with out-of-hospital cardiac arrests (OHCAs) with those with in-hospital cardiac arrests (IHCAs).

View Article and Find Full Text PDF

Introduction: Pacing-induced cardiomyopathy (PICM) is a potential complication of chronic right ventricular (RV) pacing, but its characterization in adult patients is often complicated by pre-existing cardiomyopathy. This study investigated the incidence of PICM in patients with congenital heart block (cHB) who have conduction disease from birth without confounding pre-existing cardiac conditions.

Methods And Results: This retrospective cohort analysis included 42 patients with cHB and baseline left ventricular ejection fraction (LVEF) ≥50%.

View Article and Find Full Text PDF

In conjunction with radio-chemotherapy, pulmonary resection is recommended for early-stage nonsmall- cell lung carcinoma but not for advanced-stage NSCLC patients having high-grade metastatic lesions. In these cases, the rapid Arc-Stereotactic body radiotherapy (Ra-SBRT) technique offers a therapeutic advantage by delivering focal irradiation to metastatic lung lesions and reduces the bystander toxicity to normal tissues. We have previously demonstrated that Ra-SBRT ablates metastatic lesions and induces tumor immune rejection of metastatic tumors by promoting in situ programming of M2 TAM towards M1-TAM and infiltration of Siglec-8+ Eosinophils.

View Article and Find Full Text PDF